BioAgilytix at EBF 2026

Nov 17–19, 2026 Barcelona, Spain ~800 attendees Website

BioAgilytix brings 4 presentations to EBF 2026 in Barcelona. Its program covers PK assay design, from a generic preclinical assay to an ultra-sensitive clinical one. It also compares ligand-binding and LC–MS readouts for total antibody and total ADC, and looks at DNA and RNA extraction for PCR assay validation.

Organization	EBF 2026 Attendance
BioAgilytix Durham, North Carolina	◇Sponsor
bioagilytix.com Bioanalytical CROsSponsor Bioanalytical CRO specialising in large-molecule PK, immunogenicity, biomarker and cell-based assays, with labs in the US and Europe.	Talk Tue Nov 17 11:50am–12:10pm Part of Session 2: Smarter Workflows: From Implementation to Scientific Confidence Fit-for-Purpose Implementation of a Generic Preclinical PK Assay: Lessons from Platform Transfer and Troubleshooting Ligand binding Talk Tue Nov 17 5:40–6pm Part of Session 9: New technologies and emerging modalities in Bioanalysis: PCR Considering DNA & RNA Extraction for PCR-Based Assay Validations PCR Talk Wed Nov 18 12:20–12:40pm Part of Session 13: BioA Clinic Cross-Platform Evaluation of Total Antibody and Total ADC PK: LBA versus LC-MS New modalities · LC–MS Talk Thu Nov 19 11:10–11:30am Part of Session 20: Pushing the Limits of Sensitivity and Multiplexing in Bioanalysis Responding to Evolving Clinical Needs: A Collaborative Journey to an Ultra-Sensitive PK Assay Ligand binding

Organization

EBF 2026 Attendance

BioAgilytix

Durham, North Carolina

bioagilytix.com

Bioanalytical CROsSponsor

Bioanalytical CRO specialising in large-molecule PK, immunogenicity, biomarker and cell-based assays, with labs in the US and Europe.

Talk

Tue Nov 17
11:50am–12:10pm

Part of Session 2: Smarter Workflows: From Implementation to Scientific Confidence

Fit-for-Purpose Implementation of a Generic Preclinical PK Assay: Lessons from Platform Transfer and Troubleshooting

Ligand binding